Understanding the core differences between semaglutide and tirzepatide helps contextualize why the transition requires careful management of timing, and why the side effect profiles differ
While it doesn't address the underlying trigger, "by supporting cellular signalling, reducing inflammation and promoting scalp health, it can complement a treatment plan focused on correcting the root cause," says Gaboardi
Running three to four week mesocycles with planned deload weeks prevents cumulative fatigue and keeps performance trending upward
It is not available on the NHS
Range of motion during daily activities increases
For example, this may be the case in a specific formulation that FDA-approved options cannot address, as documented by the prescribing clinician